 |
市場調查報告書
商品編碼
1629180
糖尿病胃輕癱市場，按類型、治療、配銷通路、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測Diabetic Gastroparesis Market, By Types, By Treatment, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032 |
||||||
價格
簡介目錄
報告要點
2023年，糖尿病胃輕癱市場規模為19.749億美元，2024年至2032年複合年成長率為4.30%。
糖尿病胃輕癱市場-市場動態
糖尿病盛行率上升導致市場需求激增
不斷增加的糖尿病病例正在推動市場需求，國際糖尿病聯合會報告稱，截至2021年，全球糖尿病病例已達5.37億。擴大了相關治療的市場。然而，糖尿病患者對胃輕癱的認知有限，限制了早期診斷和治療，影響了市場成長。相反，胃輕癱藥物療法的不斷創新為全球糖尿病胃輕癱市場的成長提供了充滿希望的機會。此外，全球老年人口的不斷增加增加了對有效胃輕癱治療的需求，尤其是老年糖尿病患者。
糖尿病胃輕癱市場 - 主要見解
根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 4.30% 左右的複合年成長率成長
根據類型細分，預計 3 級將在 2023 年顯示最大的市場佔有率
從治療細分來看，2023年藥物治療是主導細分
按地區分類，北美是 2023 年的主要收入來源
糖尿病胃輕癱市場-細分分析：
全球糖尿病胃輕癱市場根據類型、治療、配銷通路和地區進行細分。
市場依類型分為兩類：3級（胃衰竭）和2級（代償性胃輕癱）。 3 級（胃衰竭）領域主導市場。這種情況的嚴重性需要更強化的治療和管理方案，這推動了市場的更高需求。
市場根據治療分為兩類：手術治療和藥物治療。藥物治療領域在市場中佔據主導地位，並可能在預測期內保持其主導地位。與手術相比，它提供了侵入性較小的選擇，並包括一系列可有效控制症狀的藥物，如促動力劑和止吐劑。
糖尿病胃輕癱市場-地理洞察
從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區以及中東和非洲地區。這些區域根據開展業務的國家進一步分類。
糖尿病胃輕癱市場-競爭格局：
由於糖尿病病例的增加和對有針對性的治療方案的需求，全球市場正在擴大。公司正致力於開發有效解決胃輕癱症狀的創新療法，同時改善藥物配方以提高患者的依從性。策略合作、臨床試驗和研發投資是將新療法推向市場的核心策略，而一些公司則探索區域合作夥伴關係，以改善新興市場的准入並最佳化分銷網路。
最新進展：
2024 年 6 月，Renexxion Ireland Limited 獲得 FDA 批准那羅那必利的研究新藥 (IND) 申請，那羅那必利是一種旨在治療胃輕癱的口服藥物。這種有前景的藥物旨在解決與胃排空緩慢相關的症狀，例如噁心和嘔吐，從而推進胃腸道疾病的治療選擇。
目錄
第 1 章：糖尿病胃輕癱市場概述
- 研究範圍
- 市場預估年份
第 2 章：執行摘要
- 市場片段
- 按類型分類的糖尿病胃輕癱市場片段
- 糖尿病胃輕癱治療市場片段
- 按配銷通路分類的糖尿病胃輕癱市場片段
- 按國家/地區分類的糖尿病胃輕癱市場片段
- 按地區分類的糖尿病胃輕癱市場片段
- 競爭洞察
第 3 章：糖尿病胃輕癱主要市場趨勢
- 糖尿病胃輕癱市場促進因素
- 市場促進因素的影響分析
- 糖尿病胃輕癱市場限制
- 市場限制影響分析
- 糖尿病胃輕癱市場機會
- 糖尿病胃輕癱市場未來趨勢
第 4 章：糖尿病胃輕癱產業研究
- PEST分析
- 波特五力分析
- 成長前景圖
- 規範架構分析
第 5 章：糖尿病胃輕癱市場：地緣政治緊張局勢升級的影響
- COVID-19 大流行的影響
- 俄羅斯-烏克蘭戰爭的影響
- 中東衝突的影響
第 6 章：糖尿病胃輕癱市場格局
- 2023 年糖尿病胃輕癱市場佔有率分析
- 按主要製造商分類的故障數據
- 既有參與者分析
- 新興參與者分析
第 7 章：糖尿病胃輕癱市場 - 按類型
- 概述
- 按類型分類的細分市場佔有率分析
- 3 級（胃衰竭）
- 2級（代償性胃輕癱）
第 8 章：糖尿病胃輕癱市場 - 依治療分類
- 概述
- 按處理方式分類的細分市場佔有率分析
- 手術
- 藥物治療
- 止吐劑
- 促動力
- 肉毒桿菌
- 其他
第 9 章：糖尿病胃輕癱市場 - 按配銷通路
- 概述
- 按配銷通路分類的細分市場佔有率分析
- 網路藥局
- 零售藥局
- 醫院藥房
第 10 章：糖尿病胃輕癱市場 - 依地理位置
- 介紹
- 按地理位置分類的細分市場佔有率分析
- 北美洲
- 概述
- 北美糖尿病胃輕癱主要製造商
- 北美市場規模和預測（按國家）
- 北美市場規模和預測（按類型）
- 北美市場規模與預測（以不同處理方式）
- 北美市場規模和預測（按配銷通路）
- 美國
- 加拿大
- 歐洲
- 概述
- 歐洲糖尿病胃輕癱主要製造商
- 歐洲市場規模和預測（按國家）
- 歐洲市場規模與預測（按類型）
- 歐洲市場規模與預測（按處理方式）
- 歐洲市場規模和預測（按配銷通路）
- 德國
- 義大利
- 英國
- 法國
- 俄羅斯
- 荷蘭
- 瑞典
- 波蘭
- 歐洲其他地區
- 亞太地區 (APAC)
- 概述
- 亞太地區糖尿病胃輕癱主要製造商
- 亞太地區市場規模與預測（按國家）
- 亞太地區市場規模與預測（按類型）
- 亞太地區市場規模與預測（以不同處理方式）
- 亞太地區市場規模和預測（按配銷通路）
- 印度
- 中國
- 日本
- 韓國
- 澳洲
- 泰國
- 印尼
- 菲律賓
- 亞太地區其他地區
- 拉丁美洲
- 概述
- 拉丁美洲糖尿病胃輕癱主要製造商
- 拉丁美洲市場規模與預測（按國家）
- 拉丁美洲市場規模與預測（按類型）
- 拉丁美洲市場規模與預測（以不同處理方式）
- 拉丁美洲市場規模和預測（按配銷通路）
- 巴西
- 墨西哥
- 阿根廷
- 哥倫比亞
- 拉丁美洲其他地區
- 中東和非洲
- 概述
- 中東和非洲糖尿病胃輕癱主要製造商
- 中東和非洲市場規模及預測（按國家）
- 中東和非洲市場規模及預測（按類型）
- 中東及非洲市場規模及預測（依不同處理方式）
- 中東和非洲市場規模及預測（按配銷通路）
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 土耳其
- 阿爾及利亞
- 埃及
- MEA 的其餘部分
第 11 章：主要供應商分析-糖尿病胃輕癱產業
- 競爭儀表板
- Competitive Benchmarking
- Competitive Positioning
- 公司簡介
- Theravance Biopharma
- Allergan
- Abbott
- AstraZeneca
- Evoke Pharma
- Cadila Pharmaceuticals
- Neurogastrx, Inc.
- Eli Lilly and Company
- Bausch Health
- Teva Pharmaceutical Industries Ltd.
- Alfa Wassermann SPA
- Takeda Pharmaceutical Company Limited
- Boston Scientific Corporation
- Cardinal Health, Inc.
- CR Bard, Inc.
- Halyard Health, Inc.
- Kimberly-Clark Corporation
- Janssen Global Services, LLC
- Medtronic
- Rhythm Pharmaceuticals, Inc.
- Others
第 12 章：360 度分析師視角
第 13 章：附錄
- 研究方法
- 參考
- 縮寫
- 免責聲明
- 聯絡我們
簡介目錄
Product Code: ANV4440
REPORT HIGHLIGHT
Diabetic gastroparesis market size was valued at USD 1,974.90 Million in 2023, expanding at a CAGR of 4.30% from 2024 to 2032.
Diabetic Gastroparesis is a digestive disorder where diabetes damages the vagus nerve, slowing stomach muscle function. This impairs stomach emptying, causing food to remain longer than normal, leading to symptoms like nausea, bloating, vomiting, and fluctuating blood sugar levels. It is common in individuals with long-term or poorly controlled diabetes, particularly type 1. Managing it involves dietary adjustments, blood sugar control, and, in some cases, medications or other therapies.
Diabetic Gastroparesis Market- Market Dynamics
Rising prevalence of diabetes to surge the market demand
The increasing number of diabetes cases is driving market demand, with International Diabetes federation reporting 537 million global diabetes cases as of 2021. Besides, an aging population and lifestyle changes contribute to more diabetes and gastroparesis cases, expanding the market for related treatments. However, limited awareness among diabetic patients about gastroparesis restricts early diagnosis and treatment, affecting market growth. On the contrary, continuous innovation in gastroparesis drug therapies offers promising opportunities for the global diabetic gastroparesis market growth. Furthermore, the rising geriatric population worldwide increases the demand for effective gastroparesis treatments, especially for elderly diabetes patients.
Diabetic Gastroparesis Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.30% over the forecast period (2024-2032)
Based on types segmentation, grade 3 was predicted to show maximum market share in the year 2023
Based on treatment segmentation, pharmacological treatment was the leading segment in 2023
On the basis of region, North America was the leading revenue generator in 2023
Diabetic Gastroparesis Market- Segmentation Analysis:
The Global Diabetic Gastroparesis Market is segmented on the basis of Types, Treatment, Distribution Channel, and Region.
The market is divided into two categories based on types: grade 3 (gastric failure) and grade 2 (compensated gastroparesis). The grade 3 (gastric failure) sector dominates the market. The severe nature of this condition, which demands more intensive treatment and management options is driving higher demand in the market.
The market is divided into two categories based on treatment: surgery and pharmacological treatment. The pharmacological treatment sector dominates the market and is likely to maintain its dominance during the forecast period. It offers less invasive options compared to surgery and includes a range of drugs like prokinetics and antiemetics, which are effective in symptom management.
Diabetic Gastroparesis Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Diabetic Gastroparesis Market- Competitive Landscape:
The global market is expanding due to rising cases of diabetes and the demand for targeted treatment options. Companies are focusing on developing innovative therapies that address gastroparesis symptoms effectively, alongside improving drug formulations to enhance patient adherence. Strategic collaborations, clinical trials, and R&D investments are core strategies employed to bring novel treatments to market, while some companies explore regional partnerships to improve access in emerging markets and optimize distribution networks.
Recent Developments:
In June 2024, Renexxion Ireland Limited received FDA approval for an Investigational New Drug (IND) application for naronapride, an oral medication designed to treat gastroparesis. This promising drug aims to address symptoms associated with slow gastric emptying, such as nausea and vomiting, advancing treatment options for gastrointestinal disorders.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL DIABETIC GASTROPARESIS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Theravance Biopharma
- Allergan
- Abbott
- AstraZeneca
- Evoke Pharma
- Cadila Pharmaceuticals
- Neurogastrx, Inc.
- Eli Lilly and Company
- Bausch Health
- Teva Pharmaceutical Industries Ltd.
- Alfa Wassermann SPA
- Takeda Pharmaceutical Company Limited
- Boston Scientific Corporation
- Cardinal Health, Inc.
- C. R. Bard, Inc.
- Halyard Health, Inc.
- Kimberly-Clark Corporation
- Janssen Global Services, LLC
- Medtronic
- Rhythm Pharmaceuticals, Inc.
- Others
GLOBAL DIABETIC GASTROPARESIS MARKET, BY TYPES- MARKET ANALYSIS, 2019 - 2032
- Grade 3 (Gastric Failure)
- Grade 2 (Compensated Gastroparesis)
GLOBAL DIABETIC GASTROPARESIS MARKET, BY TREATMENT- MARKET ANALYSIS, 2019 - 2032
- Surgical
- Pharmacological Treatment
- Antiemetic Agents
- Prokinetics
- Botulinum
- Others
GLOBAL DIABETIC GASTROPARESIS MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032
- Online Pharmacies
- Retail Pharmacies
- Hospital Pharmacies
GLOBAL DIABETIC GASTROPARESIS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. Diabetic Gastroparesis Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Diabetic Gastroparesis Market Snippet by Types
- 2.1.2. Diabetic Gastroparesis Market Snippet by Treatment
- 2.1.3. Diabetic Gastroparesis Market Snippet by Distribution Channel
- 2.1.4. Diabetic Gastroparesis Market Snippet by Country
- 2.1.5. Diabetic Gastroparesis Market Snippet by Region
- 2.2. Competitive Insights
3. Diabetic Gastroparesis Key Market Trends
- 3.1. Diabetic Gastroparesis Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Diabetic Gastroparesis Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Diabetic Gastroparesis Market Opportunities
- 3.4. Diabetic Gastroparesis Market Future Trends
4. Diabetic Gastroparesis Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Diabetic Gastroparesis Market: Impact of Escalating Geopolitical Tensions
- 5.1. Impact of COVID-19 Pandemic
- 5.2. Impact of Russia-Ukraine War
- 5.3. Impact of Middle East Conflicts
6. Diabetic Gastroparesis Market Landscape
- 6.1. Diabetic Gastroparesis Market Share Analysis, 2023
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Diabetic Gastroparesis Market - By Types
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Types, 2023 & 2032 (%)
- 7.1.2. Grade 3 (Gastric Failure)
- 7.1.3. Grade 2 ( Compensated Gastroparesis)
8. Diabetic Gastroparesis Market - By Treatment
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Treatment, 2023 & 2032 (%)
- 8.1.2. Surgery
- 8.1.3. Pharmacological Treatment
- 8.1.3.1. Antiemetic Agents
- 8.1.3.2. Prokinetics
- 8.1.3.3. Botulinum
- 8.1.3.4. Others
9. Diabetic Gastroparesis Market - By Distribution Channel
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Distribution Channel, 2023 & 2032 (%)
- 9.1.2. Online Pharmacies
- 9.1.3. Retail Pharmacies
- 9.1.4. Hospital Pharmacies
10. Diabetic Gastroparesis Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Diabetic Gastroparesis Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Diabetic Gastroparesis Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.8.3. Italy Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.3.8.4. Italy Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.9.3. United Kingdom Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.3.9.4. United Kingdom Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.10. France
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.10.3. France Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.3.10.4. France Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
- 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.11.2. Russia Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.3.11.3. Russia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
- 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.12.2. Netherlands Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.3.12.3. Netherlands Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.13.2. Sweden Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
- 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.14.2. Poland Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.3.14.3. Poland Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.15.3. Rest of the Europe Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.3.15.4. Rest of the Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Diabetic Gastroparesis Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.7. India
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.7.3. India Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.4.7.4. India Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.8. China
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.8.3. China Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.4.8.4. China Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.12.3. Thailand Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.4.12.4. Thailand Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.13.3. Indonesia Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.4.13.4. Indonesia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Diabetic Gastroparesis Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Diabetic Gastroparesis Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.8.3. United Arab Emirates Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.6.8.4. United Arab Emirates Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Diabetic Gastroparesis Industry
- 11.1. Competitive Dashboard
- 11.1.1. Competitive Benchmarking
- 11.1.2. Competitive Positioning
- 11.2. Company Profiles
- 11.2.1. Theravance Biopharma
- 11.2.2. Allergan
- 11.2.3. Abbott
- 11.2.4. AstraZeneca
- 11.2.5. Evoke Pharma
- 11.2.6. Cadila Pharmaceuticals
- 11.2.7. Neurogastrx, Inc.
- 11.2.8. Eli Lilly and Company
- 11.2.9. Bausch Health
- 11.2.10. Teva Pharmaceutical Industries Ltd.
- 11.2.11. Alfa Wassermann SPA
- 11.2.12. Takeda Pharmaceutical Company Limited
- 11.2.13. Boston Scientific Corporation
- 11.2.14. Cardinal Health, Inc.
- 11.2.15. C. R. Bard, Inc.
- 11.2.16. Halyard Health, Inc.
- 11.2.17. Kimberly-Clark Corporation
- 11.2.18. Janssen Global Services, LLC
- 11.2.19. Medtronic
- 11.2.20. Rhythm Pharmaceuticals, Inc.
- 11.2.21. Others
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us
02-2729-4219
+886-2-2729-4219
糖尿病胃輕癱治療市場－全球產業規模、佔有率、趨勢、機會和預測，按類型（2 級、3 級）、按藥物類別、按給藥途徑、按配銷通路、按地區和競爭進行細分，2020 年至 2030 年預測
胃輕癱治療市場按藥物類別、疾病適應症、類型、給藥途徑、分銷管道和地區分類
胃輕癱治療市場，按藥物類別、類型、給藥途徑、疾病適應症、配銷通路、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測胃輕癱治療市場 - 全球產業分析、規模、佔有率、成長、趨勢和預測，2024-2034 年糖尿病性胃輕癱治療市場:各產品類型，各適應疾病，各流通管道，各地區:市場規模，佔有率，展望，機會分析，2023年～2030年